80 Participants Needed

VR Therapy for Bone Marrow Transplant

Areej El-Jawahri, MD profile photo
Overseen ByAreej El-Jawahri, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment BMT-VR for patients undergoing bone marrow transplant?

Research shows that virtual reality (VR) can help reduce symptoms like anxiety, depression, and pain in patients undergoing treatments similar to bone marrow transplants. VR has also been effective in improving quality of life and managing symptoms in cancer patients, suggesting it could be beneficial for those undergoing bone marrow transplants.12345

How is the BMT-VR treatment different from other treatments for bone marrow transplant patients?

BMT-VR is unique because it uses virtual reality as a psychosocial intervention to help bone marrow transplant patients cope with psychological stress and improve their quality of life, unlike traditional treatments that focus primarily on medical and physical aspects.678910

What is the purpose of this trial?

The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone.The BMT-VR intervention has several components:1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports.2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes.3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care

Research Team

Areej R. El-Jawahri, MD - Mass General ...

Areej El-Jawahri, MD

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

This trial is for English-speaking adults over 18 with blood cancer, admitted for bone marrow transplantation (BMT). It's not suitable for those with benign blood conditions or acute psychiatric/cognitive issues that prevent informed consent or following the study.

Inclusion Criteria

I am over 18 and have a blood cancer, scheduled for a bone marrow transplant.
Ability to comprehend, read, and respond to questions in English as BMT-VR is only available in English

Exclusion Criteria

I am receiving a bone marrow transplant as an outpatient.
Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures
I am having a bone marrow transplant for a non-cancerous blood condition.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the BMT-VR intervention during their BMT hospitalization, which includes six sections focused on education and coping strategies

During hospitalization
Inpatient

Follow-up

Participants are monitored for quality of life and psychological outcomes through questionnaires at baseline, 2, 4, 12, and 24 weeks

24 weeks
Questionnaires at baseline, 2, 4, 12, and 24 weeks

Extension

Participants may continue to be monitored for long-term outcomes beyond the initial follow-up period

Beyond 24 weeks

Treatment Details

Interventions

  • BMT-VR
Trial Overview The study tests a virtual reality (VR) program designed to improve life quality and reduce stress in BMT patients. Participants will either receive this VR intervention plus standard care, or just standard care, assigned randomly.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: BMT-VR GroupExperimental Treatment1 Intervention
* Participants will complete the BMT-VR intervention during their BMT hospitalization, which contains six sections. * Participants will receive usual transplant care by their BMT team * Participants will complete study questionnaires to assess their quality of life and psychological outcomes * 10-20 participants will complete exit interviews to ascertain more feedback on the BMT-VR intervention.
Group II: Usual careActive Control1 Intervention
* Participants will receive usual transplant care by their BMT team * Participants will complete study questionnaires to assess their quality of life and psychological outcomes

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

Findings from Research

Virtual reality (VR) interventions have been shown to significantly reduce symptoms of anxiety, depression, pain, and fatigue in cancer patients, based on a meta-analysis of 6 studies.
The findings suggest that while VR is effective for managing acute symptoms during cancer treatment, further research is needed to explore its benefits for long-term side effects in cancer survivorship care.
Meta-Analysis of the Efficacy of Virtual Reality-Based Interventions in Cancer-Related Symptom Management.Zeng, Y., Zhang, JE., Cheng, ASK., et al.[2020]
A systematic review of 17 studies involving 799 cancer patients found that virtual reality (VR) significantly improved pain, anxiety, upper extremity function, and quality of life after intervention, indicating its efficacy in cancer rehabilitation.
VR not only alleviated physical and psychological symptoms but also showed positive effects on cognitive function, suggesting it can be a valuable addition to comprehensive cancer rehabilitation programs.
Effects of virtual reality on physical, cognitive, and psychological outcomes in cancer rehabilitation: a systematic review and meta-analysis.Hao, J., Li, Y., Swanson, R., et al.[2023]
In a study involving 20 hospitalized participants aged 19-70, virtual reality (VR) sessions significantly improved 8 out of 10 symptoms related to distress, including depression, anxiety, and pain, after receiving allogeneic hematopoietic stem cell transplantation.
The findings suggest that VR is a promising low-cost intervention for alleviating distressing symptoms in patients post-transplant, highlighting its potential for further research in managing prolonged hospitalizations.
Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Quality Improvement Initiative.Vega, C., Whitney, RL., Hannah, J., et al.[2022]

References

Meta-Analysis of the Efficacy of Virtual Reality-Based Interventions in Cancer-Related Symptom Management. [2020]
Effects of virtual reality on physical, cognitive, and psychological outcomes in cancer rehabilitation: a systematic review and meta-analysis. [2023]
Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Quality Improvement Initiative. [2022]
Guided imagery relaxation in quality of life of patients undergoing hematopoietic stem cell transplantation: a quasi-experiment. [2022]
Virtual reality interventions and the outcome measures of adult patients in acute care settings undergoing surgical procedures: An integrative review. [2022]
Quality of life following bone marrow transplantation. [2019]
Psychological distress among adult patients being evaluated for bone marrow transplantation. [2007]
Psychiatric and psychosocial aspects of bone marrow transplantation. [2007]
Art therapy with adult bone marrow transplant patients in isolation: a pilot study. [2019]
Psychosocial factors in bone marrow transplantation: a review and recommendations for research. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security